CONTINUED... Read this and more news for Oncolytics Biotech at: In other recent industry developments and happenings in the m ...

Merck (MRK) stock in focus as anti-cancer agent Welireg is approved in the EU for kidney tumor conditions, VHL disease and ...

She’s had two healthy pregnancies since undergoing the trial, which uses modified white blood cells to attack cancer cells. Doctors believe she's the longest-surviving cancer patient to have received ...

Cardiff Oncology's Onvansertib shows promise in treating RAS-mutated cancers, especially mCRC. See why I rate CRDF stock as a ...

Furin is identified as the key enzyme responsible for cleaving the apelin precursor. Inhibiting this cleavage could serve as ...

Stem cell therapy for hair loss is a new treatment that can gained precedence recently. Check out how it works and what to keep in mind while getting it done.

Buying stocks that sell for 100 times revenue or more means facing terrible odds. Of 84 such stocks covered in this column, ...

The Bladder Cancer Company, announces the presentation on February 14 of a new abstract with study results from its U.S.

British professor Paul Workman has announced a major breakthrough for rare and untreatable bone cancer chordoma.

University of Denver professor Dali Sun used his engineering background to envision a machine that would expedite cancer cell ...

Most major sections of the new animal drug application for Laverdia-CA1 have been deemed complete by the FDA, bringing the ...

Approval of Adcetris provides a new treatment option for patients with relapsed or refractory large b-cell lymphoma who are ...